Cargando…

Correction: A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial

Detalles Bibliográficos
Autores principales: Huang, Zhilian, Tan, Eberta, Lum, Elaine, Sloot, Peter, Boehm, Bernhard Otto, Car, Josip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221638/
https://www.ncbi.nlm.nih.gov/pubmed/32348282
http://dx.doi.org/10.2196/18411
_version_ 1783533406764662784
author Huang, Zhilian
Tan, Eberta
Lum, Elaine
Sloot, Peter
Boehm, Bernhard Otto
Car, Josip
author_facet Huang, Zhilian
Tan, Eberta
Lum, Elaine
Sloot, Peter
Boehm, Bernhard Otto
Car, Josip
author_sort Huang, Zhilian
collection PubMed
description
format Online
Article
Text
id pubmed-7221638
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-72216382020-05-18 Correction: A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial Huang, Zhilian Tan, Eberta Lum, Elaine Sloot, Peter Boehm, Bernhard Otto Car, Josip JMIR Mhealth Uhealth Corrigenda and Addenda JMIR Publications 2020-04-29 /pmc/articles/PMC7221638/ /pubmed/32348282 http://dx.doi.org/10.2196/18411 Text en ©Zhilian Huang, Eberta Tan, Elaine Lum, Peter Sloot, Bernhard Otto Boehm, Josip Car. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 29.04.2020. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mHealth and uHealth, is properly cited. The complete bibliographic information, a link to the original publication on http://mhealth.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Corrigenda and Addenda
Huang, Zhilian
Tan, Eberta
Lum, Elaine
Sloot, Peter
Boehm, Bernhard Otto
Car, Josip
Correction: A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial
title Correction: A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial
title_full Correction: A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial
title_fullStr Correction: A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial
title_full_unstemmed Correction: A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial
title_short Correction: A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial
title_sort correction: a smartphone app to improve medication adherence in patients with type 2 diabetes in asia: feasibility randomized controlled trial
topic Corrigenda and Addenda
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221638/
https://www.ncbi.nlm.nih.gov/pubmed/32348282
http://dx.doi.org/10.2196/18411
work_keys_str_mv AT huangzhilian correctionasmartphoneapptoimprovemedicationadherenceinpatientswithtype2diabetesinasiafeasibilityrandomizedcontrolledtrial
AT taneberta correctionasmartphoneapptoimprovemedicationadherenceinpatientswithtype2diabetesinasiafeasibilityrandomizedcontrolledtrial
AT lumelaine correctionasmartphoneapptoimprovemedicationadherenceinpatientswithtype2diabetesinasiafeasibilityrandomizedcontrolledtrial
AT slootpeter correctionasmartphoneapptoimprovemedicationadherenceinpatientswithtype2diabetesinasiafeasibilityrandomizedcontrolledtrial
AT boehmbernhardotto correctionasmartphoneapptoimprovemedicationadherenceinpatientswithtype2diabetesinasiafeasibilityrandomizedcontrolledtrial
AT carjosip correctionasmartphoneapptoimprovemedicationadherenceinpatientswithtype2diabetesinasiafeasibilityrandomizedcontrolledtrial